
Immdal is continually seeking opportunities to in-license new products and technologies that fit our product portfolio and company development strategy for markets in the United Kingdom, Republic of Ireland and beyond.
Immdal is interested in potential collaborators who are prepared to invest in the development of the company, its clinical study program, intellectual property and market development.
Enquiries from financial and trade investors should be directed to our Chief Executive Officer.